DE4Bios, our Digital Enabler-based bio-surveillance platform, provides updated status information in real time on the evolving epidemic. Helping doctors and local authorities work in safety
Slowing and monitoring the evolving pandemic. Supporting health authority decision-making regarding restrictions
An ecosystem platform that can integrate diverse transversal data sources, combined with data analytic models that glean knowledge from cross-cutting information
Quickly identify subjects for testing. Pinpoint areas most at risk in order to facilitate strategic decision-making
An ecosystem platform that fights the pandemic
This provides updated status information in real time on the evolving pandemic while respecting privacy. Using our Digital Enabler ecosystem platform, you can map and geolocate infected subjects and detect clusters requiring urgent attention.
DE4Bios makes it possible to show the concentration of a phenomenon in a territory or more narrowly defined area. This can help health authorities make the most appropriate decisions in terms of restricting personal mobility or access to a crisis areas. It also allows predictive analysis of the evolving infection situation and identifying areas where COVID-19 is most likely to spread. This lets health facilities organize in time.
Protecting public health
Over the last year, DE4Bios has developed and kept up with the pandemic’s continually changing scenarios. Beginning with the first lockdown, it was used to monitor potential clusters linked to businesses or schools. It was also used to track COVID variant trends and the progress of vaccine activity.
"DE4Bios has highlighted another value of the data - concludes Lanfranco Marasso -. The value of the data which,can really contribute to saving lives, if used in a precise manner and above all with very short times. And this was precisely the most great contribution in the first phase of the Covid emergency in Italy by DE4Bios ".
Fight the contagion
Identify and predict the areas most at risk
Define strategies and intervention priorities
Identify new subjects on whom to carry out tests
AI & Advanced Analytics
Engineering proprietary products & other technologies
Research & Innovation